It is a software-as-a-service company that utilises artificial intelligence to improve the early detection of breast cancer by analysing breast images.
It says it is on track to meet its guidance for the financial year of NZ$17.1 million.
It also confirmed that with the addition of the medical software company, MRS Systems Incorporated, its US market share has reached approximately 25 per cent.
Shares in Volpara Health Technologies (ASX:VHT) closed 2.59 per cent lower at $1.51 yesterday.